United States · FDA National Drug Code directory

Citalopram

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68071-3357_3880e5dd-0433-2990-e063-6394a90a0ef8
Product NDC
68071-3357
Form
TABLET, FILM COATED
Composition / generic term
Citalopram Hydrobromide
Labeler
NuCare Pharmaceuticals,Inc.
Marketing category
ANDA
Marketing start / end (source format)
20041028
Source listing expiry
20261231

Source-listed ingredients

  • CITALOPRAM HYDROBROMIDE — 40 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 15 TABLET, FILM COATED in 1 BOTTLE (68071-3357-1) · 68071-3357-1
  • 30 TABLET, FILM COATED in 1 BOTTLE (68071-3357-3) · 68071-3357-3
  • 40 TABLET, FILM COATED in 1 BOTTLE (68071-3357-4) · 68071-3357-4
  • 45 TABLET, FILM COATED in 1 BOTTLE (68071-3357-5) · 68071-3357-5
  • 60 TABLET, FILM COATED in 1 BOTTLE (68071-3357-6) · 68071-3357-6
  • 90 TABLET, FILM COATED in 1 BOTTLE (68071-3357-9) · 68071-3357-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →